Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026)
Rapid Micro Biosystems' (RPID) quarterly Depreciation & Amortization (CF) came in at $706000.0 in Q1 2026, down 16.65% year-on-year from $847000.0 in Q1 2025, and down 10.63% quarter-over-quarter from $790000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $706000.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $706000.0, down 16.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (down 8.58% YoY), and the FY2025 annual result was $3.3 million, down 3.27% from the prior year.
- Depreciation & Amortization (CF) came in at $706000.0 for Q1 2026 at Rapid Micro Biosystems, down from $790000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $869000.0 in Q4 2024 to a low of $560000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $794000.0 (2023), against an average of $780117.6.
- Across the five-year window, Depreciation & Amortization (CF) soared 127.67% in 2022 and fell 16.65% in 2026, its largest moves.
- Rapid Micro Biosystems' Depreciation & Amortization (CF) stood at $860000.0 in 2022, then declined by 7.67% to $794000.0 in 2023, then climbed by 9.45% to $869000.0 in 2024, then decreased by 9.09% to $790000.0 in 2025, then slipped by 10.63% to $706000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $706000.0 (Q1 2026), $790000.0 (Q4 2025), and $804000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Rapid Micro Biosystems | 77.24 Mn | 54.29 Mn | 371,000.00 | 706,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 706,000.00 |
| Mar 31, 2026 | 706,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Dec 31, 2023 | 794,000.00 |
| Dec 31, 2023 | 794,000.00 |